GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SymBio Pharmaceuticals Ltd (TSE:4582) » Definitions » Policy Acquisition Expense

SymBio Pharmaceuticals (TSE:4582) Policy Acquisition Expense


View and export this data going back to 2011. Start your Free Trial

What is SymBio Pharmaceuticals Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


SymBio Pharmaceuticals (TSE:4582) Business Description

Traded in Other Exchanges
Address
5-23-7 Shimbashi, San-Ei Building, 8th Floor, Minato-ku, Tokyo, JPN, 105-0004
SymBio Pharmaceuticals Ltd is a biopharmaceutical company engaged in manufacturing and commercializing drugs for oncology, hematology, and pain management.